Common Contracts
3 similar Non-Qualified Stock Option Agreement contracts by iBio, Inc., Cortigent, Inc.
NON-QUALIFIED STOCK OPTION AGREEMENT UNDER the Cortigent, inc. 2023 omnibus incentive planNon-Qualified Stock Option Agreement • May 19th, 2023 • Cortigent, Inc. • Electromedical & electrotherapeutic apparatus • Delaware
Pursuant to the Cortigent, Inc. 2023 Omnibus Incentive Plan, as amended through the date hereof (the “Plan”), (“Cortigent, Inc.” or (the “Company”) hereby grants to the Optionee named above an option (the “Stock Option”) to purchase on or prior to the Expiration Date specified above all or part of the number of shares of Common Stock of the Company (the “Stock”) specified above at the Option Exercise Price per Share specified above subject to the terms and conditions set forth herein and in the Plan. This Stock Option is not intended to be an “incentive stock option” under Section 422 of the Internal Revenue Code of 1986, as amended.
iBio, inc. NON-QUALIFIED STOCK OPTION AGREEMENT FOR NON-EMPLOYEE DIRECTORS UNDER the iBio, Inc. 2020 omnibus incentive planNon-Qualified Stock Option Agreement • January 11th, 2021 • iBio, Inc. • Pharmaceutical preparations • Delaware
Pursuant to the iBio, Inc. 2020 Omnibus Incentive Plan, as amended through the date hereof (the “Plan”), iBio, Inc. (the “Company”) hereby grants to the Optionee named above an option (the “Stock Option”) to purchase on or prior to the Expiration Date specified above all or part of the number of shares of Common Stock, par value $0.001 per share (the “Stock”), of the Company specified above at the Option Exercise Price per Share specified above subject to the terms and conditions set forth herein and in the Plan. This Stock Option is not intended to be an “incentive stock option” under Section 422 of the Internal Revenue Code of 1986, as amended.
iBio, inc. NON-QUALIFIED STOCK OPTION AGREEMENT FOR NON-EMPLOYEE DIRECTORS UNDER the iBio, Inc. 2020 omnibus incentive planNon-Qualified Stock Option Agreement • January 11th, 2021 • iBio, Inc. • Pharmaceutical preparations • Delaware
Pursuant to the iBio, Inc. 2020 Omnibus Incentive Plan, as amended through the date hereof (the “Plan”), iBio, Inc. (the “Company”) hereby grants to the Optionee named above an option (the “Stock Option”) to purchase on or prior to the Expiration Date specified above all or part of the number of shares of Common Stock, par value $0.001 per share (the “Stock”), of the Company specified above at the Option Exercise Price per Share specified above subject to the terms and conditions set forth herein and in the Plan. This Stock Option is not intended to be an “incentive stock option” under Section 422 of the Internal Revenue Code of 1986, as amended.
